- QMRO Home
- Barts Cancer Institute
- Centre for Experimental Cancer Medicine
- Comment on 'Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'
Browse
Administrators only